尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the complete record of transactions filed by Astle Christopher. Director active across 1 company, notably Zymeworks Inc.. In total, 4 filings have been recorded. Activity tracked since 12 December 2022. The latest transaction was disclosed on 5 January 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Astle Christopher is linked to Zymeworks Inc., where the listed role is SVP & Chief Financial Officer. The declarant has 4 filings in total, and the sampled filings run from 2022-12-14 to 2024-01-08, with the modal transaction nature indicated as option exercise.